ARTICLE | Company News
OxiGene falls on terminated deal
October 25, 2001 7:00 AM UTC
OxiGene (OXGN; SSE:OXGN) was off $0.42 (17%) to $2.08 on Thursday. On Wednesday after market close, OXGN said that Bristol-Myers (BMY) terminated a 1999 deal under which BMY received worldwide develop...